share_log

Evercore ISI Group Maintains Outperform on Cabaletta Bio, Lowers Price Target to $15

Benzinga ·  Aug 12 21:57  · Ratings

Evercore ISI Group analyst Gavin Clark-Gartner maintains Cabaletta Bio (NASDAQ:CABA) with a Outperform and lowers the price target from $25 to $15.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment